Artificial intelligence and the rebalanced hemostasis of chronic liver disease: From viscoelastic testing to digital twins

Chronic liver disease, particularly cirrhosis, produces a fragile, rebalanced hemostatic state. Patients may develop bleeding or thrombosis. The international normalized ratio and platelet count incompletely reflect concurrent procoagulant and anticoagulant changes and poorly predict procedural bleeding. Viscoelastic testing and thrombin-generation assays assess hemostasis more broadly. Randomized trials support viscoelastic testing-guided reductions in blood product use, but these trials do not establish prediction of later bleeding or thrombosis. Machine-learning models address gastrointestinal bleeding outcomes, variceal hemorrhage, portal vein thrombosis (PVT), and transfusion requirements using clinical records, imaging, or elastography. Most cirrhosis models address one outcome, omit direct hemostatic measurements, and have limited external validation. Within the English-language eligibility criteria and focused queries of a PubMed update on July 29, 2026, no adult model jointly estimating future bleeding and PVT in cirrhosis was identified. This structured narrative minireview evaluates the evidence for both outcomes and specifies research requirements for paired-risk models and a possible digital twin of the coagulation-portal axis. Treatment-specific predictions would require additional causal validation.

Authors

Institutions

Publication Details

Journal
World Journal of Hematology
Published
2026-11-20
DOI
https://doi.org/10.5315/wjh.126171
Primary Topic
Liver Disease and Transplantation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Artificial intelligence and the rebalanced hemostasis of chronic liver disease: From viscoelastic testing to digital twins

Ahmed Salman
World Journal of Hematology
Liver Disease and Transplantation
article

Artificial intelligence and the rebalanced hemostasis of chronic liver disease: From viscoelastic testing to digital twins

Ahmed Salman
article en

Abstract

Chronic liver disease, particularly cirrhosis, produces a fragile, rebalanced hemostatic state. Patients may develop bleeding or thrombosis. The international normalized ratio and platelet count incompletely reflect concurrent procoagulant and anticoagulant changes and poorly predict procedural bleeding. Viscoelastic testing and thrombin-generation assays assess hemostasis more broadly. Randomized trials support viscoelastic testing-guided reductions in blood product use, but these trials do not establish prediction of later bleeding or thrombosis. Machine-learning models address gastrointestinal bleeding outcomes, variceal hemorrhage, portal vein thrombosis (PVT), and transfusion requirements using clinical records, imaging, or elastography. Most cirrhosis models address one outcome, omit direct hemostatic measurements, and have limited external validation. Within the English-language eligibility criteria and focused queries of a PubMed update on July 29, 2026, no adult model jointly estimating future bleeding and PVT in cirrhosis was identified. This structured narrative minireview evaluates the evidence for both outcomes and specifies research requirements for paired-risk models and a possible digital twin of the coagulation-portal axis. Treatment-specific predictions would require additional causal validation.

World Journal of HematologyVol. 12(3)
Cairo University (EG), Cairo University hospitals (EG)
Good health and well-being
Liver Disease and Transplantation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon